Pipeline Phase Listing Configuration


Therapetic Area : bms:therapeutiic-area/hematology

Tumor : bms:tumor/multiple-myeloma

Brand Compound Name :

OPDIVO®
(nivolumab) +
EMPLICITI®
(elotuzumab)

Pipeline Phase Listing Content

Researches and their phases:::

Phase:
bms:phase/phase-2

Research Area/Line of Therapy

Relapsed/Refractory